Location History:
- Hamden, CT (US) (1994 - 2006)
- Zionsville, IN (US) (2002 - 2016)
Company Filing History:
9 out of 3,684 
2 out of 22 
2 out of 21 
Years Active: 1994-2016
Title: Kuo-Long Yu: Innovator in Antiviral and Cancer Treatment
Introduction
Kuo-Long Yu is a prominent inventor based in Zionsville, IN, known for his significant contributions to the fields of antiviral agents and cancer treatment. With a total of 12 patents to his name, Yu has made remarkable strides in developing innovative compounds that address critical health challenges.
Latest Patents
Among his latest patents, Yu has developed inhibitors of EZH2, which are compounds that inhibit the activity of the histone lysine N-methyltransferase, Enhancer of Zeste Homolog 2 (EZH2). These compounds are formulated into pharmaceutical compositions and are intended for use in treating various cancers, including hematologic and solid tumors. Another notable patent involves substituted benzimidazole antiviral agents, which are antiviral compounds designed for the treatment of viral infections, particularly respiratory syncytial virus infections.
Career Highlights
Throughout his career, Kuo-Long Yu has worked with esteemed organizations such as Bristol-Myers Squibb Company and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences. His work in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Yu has collaborated with notable colleagues, including Rita Civiello and Nicholas A Meanwell, contributing to the advancement of innovative solutions in his field.
Conclusion
Kuo-Long Yu's contributions to the fields of antiviral and cancer treatment through his patents and collaborations highlight his role as a leading inventor. His work continues to impact the medical community positively, paving the way for future innovations.